VB Pod CV (200+125) Tablet | Price, Usage, Dosage, Composition, and Brand Substitutes - Fixed-Dose Combination (FDC) Drug
VB Pod CV (200+125) Tablet
VB Pod CV (200+125) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by V&B Healthcare. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Cefpodoxime Proxetil, Clavulanate Potassium. This drug comes in the form of Tablet. The general packing available for this medicine consists of 6 Tablet and is priced at Rs 168 (arround $2.352 US Dollar)| Generic (Salt) Combination : | (Cefpodoxime Proxetil+ Clavulanate Potassium) |
| Pharma Company : | V&B Healthcare |
| Brand Label : | VB Pod CV (200+125) |
| Preparation Type : | Tablet |
| Single Dose : | 1 Tablet |
| Composition (Fixed-Dose Combination) : |
|
| Pack Size/Qty/Vol : | 6 Tablet |
| Price Unit : | Rs 28 INR (arround $0.392 US Dollar) |
| Price Pack : | Rs 168 INR (arround $2.352 US Dollar) |
Drug details for VB Pod CV (200+125)
Usage: Why is this medication prescribed?
The main active ingredients or salts in VB Pod CV (200+125) are :
Cefpodoxime Proxetil
Indication (Prescribed for or used as):
For more details on Cefpodoxime Proxetil, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Cefpodoxime Proxetil..
Clavulanate PotassiumIndication (Prescribed for or used as):
For more details on Clavulanate Potassium, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Clavulanate Potassium..
VB Pod CV (200+125) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 2 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for VB Pod CV (200+125), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Cefpodoxime Proxetil-200 mg Clavulanate Potassium-125 mg).Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.
| Brand | Price (Rs.) | Brand | Price (Rs.) |
| Cefoact CV | 192 | Jedoxime CV (200+125) | 299 |